I suggest you look at the Esense IPO thread and the first thread under this code. Esense is not a one trick cannabis pony . While the Cannabis market - primarily the vaporiser / ecigarette market is the first vertical, they will quickly move to edibles, oils, topical creams . All these markets are huge and growing quickly. Their disruptive technology - where they source organic material that is cheap and create chemical profiles of the target market with 99% accuracy can be applied to other industries such as Sandalwood, Ginseng, Truffle Mushrooms and Saffron.
If they continue performing, this is can easily get to $1.5-$2 in the next 12 months and still be cheap. This was the premise for me to participate in the IPO. No pump or Cannabis hype. Can't complain about the hype cause the share price has gone up but even without it, this is a disruptive business.
- Forums
- ASX - By Stock
- ESE
- Ann: eSense-Lab Achieves Reduction in Commercial Production Costs
Ann: eSense-Lab Achieves Reduction in Commercial Production Costs, page-143
-
- There are more pages in this discussion • 190 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ESE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online